Literature DB >> 35606264

Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?

Miguel Muñoz1, Miguel E Muñoz2, Ferran Morell3, Rafael Coveñas4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35606264     DOI： 10.1016/j.arbres.2022.05.004

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   6.333


× No keyword cloud information.
  1 in total

1.  Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer.

Authors:  Rafael Coveñas; Miguel Muñoz
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.